Naltrexone Hydrochloride Tablet Shortage: Supply Updates and Manufacturer Status

What’s in Shortage

Naltrexone Hydrochloride tablets (50 mg), a medication within the Analgesia/Addiction therapeutic category, are currently listed on the FDA drug shortage database. This shortage affects the generic form and brand-name Naltrexone Hydrochloride. The shortage was first posted on February 29, 2024, and the most recent update was provided on February 5, 2026.

Which Manufacturers Are Affected

Several manufacturers are involved in the production of Naltrexone Hydrochloride 50 mg tablets, with varying levels of availability:

• Elite Laboratories, Inc.: Multiple presentations are currently Available. Some of these are marketed by Precision Dose or Tagi Pharma. (Contact: 888-852-6657; Customer service for marketed products: 800-397-9228).
• Accord Healthcare Inc.: 50 mg tablets are Available. (Contact: 866-941-7857, option 2).
• Sun Pharmaceutical Industries, Inc.: Availability is mixed. While some presentations remain Available, others (NDC 47335-326-08 and 47335-326-18) are Unavailable and noted as currently not marketed. (Contact: 800-818-4555).
• Chartwell Molecular Holdings LLC: 50 mg tablets are Available. (Contact: 845-268-5000 Ext. 510).
• SpecGx LLC: 50 mg tablets are Available. (Contact: 800-325-8888).

Why There’s a Shortage

The FDA source data does not provide a specific reason for the current shortage status of Naltrexone Hydrochloride tablets.

What Patients Should Do

If you rely on this medication, please remain proactive about your prescription. You may wish to take the following steps:

• Consult your healthcare provider: Discuss your ongoing treatment and any concerns you have regarding medication access.
• Talk to your pharmacist: Pharmacists have the most up-to-date information on local stock and can help identify which manufacturer’s products are currently in their supply chain.
• Contact manufacturers: If you are having difficulty locating the medication, you may use the contact numbers listed above to inquire about supply.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider or pharmacist regarding their medical treatment and medication options.

Source

Information attributed to the FDA Drug Shortage Database.